View speakers, slides, and presentations from previous year's symposiums.
The 6th Diabetes Prevention Symposium was held in-person on Thursday, November 9th and Friday, November 10th on the University of 麻豆传媒高清: Anschutz Medical Campus. This year's meeting covered the economics of T1D screening, practical considerations for T1D and other health screenings, and the priorities and challenges of population screening, amongst other topics. It also provided updates from current screening programs.
Click on presentation title to view talk. Click on (Slides) to view presentation slides.
Please use this link for any questions\comments regarding this event
DAY 1
Thursday, November 9, 2023 10:00 am - 4:00 pm
Barbara Davis Center, Main Conference Room 2104
1775 Aurora Court
SESSION 1: COST-EFFECTIVENESS OF POPULATION SCREENING FOR T1D
10:05-10:20 (R. Brett McQueen, Denver, USA) (Slides)
10:20-10:35 (Gonçalo Leiria, Denver, USA) (Slides)
10:35-10:50 (Lauric Ferrat, Exeter, the U.K.) (Slides)
10:50-11:00
SESSION 2: COMBINED SCREENING FOR T1D AND OTHER PEDIATRIC DISEASES
11:00-11:15 (Daniel Agardh, Malmo, Sweden) (Slides)
11:15-11:30 (Marisa Stahl and Edwin Liu, Aurora, USA) (Slides)
11:30-11:45 (Lisa Gehtland, RTI International, Durham, USA) (Slides)
11:45-12:00
12:00-12:30 Lunch
SESSION 3: PRACTICAL ASPECTS OF SCREENING FOR PRE-SYMPTOMATIC T1D
12:30-12:45 (Crystal Silva and Cristy Geno Rasmussen, Denver) (Slides)
12:45-1:00 (Holly O'Donnell, Denver) (Slides)
1:00-1:15 (Sonja O'Leary, Denver) (Slides)
1:15-1:30 (Amber Corr and Brigitte Frohnert, Denver) (Slides)
1:30-1:45
1:45-2:00 Break
SESSION 4: PRACTICAL ASPECTS OF MONITORING AND EDUCATION IN PRE-SYMPTOMATIC T1D
2:00-2:20 (Kurt Griffin, Sanford Health, Sioux Falls) (Slides)
2:20-2:40 (Kim Bautista and Patricia Gesualdo, Denver) (Slides)
2:40-3:00 (Hali Broncucia and Andrea Steck, Denver) (Slides)
3:00-3:20 (Lexie Chesshir and Kimber Simmons, Denver) (Slides)
3:20-4:00
DAY 2
Friday, November 10, 2023 8:00am - 4:40 pm
Anschutz Health Sciences Building, Room 2010/2011
1890 North Revere Court
8:00-8:05 (Marian Rewers, Denver, USA) (Slides)
SESSION 5: PRIORITIES AND CHALLENGES IN POPULATION SCREENING FOR T1D
8:05-9:00 Panel Discussion - Sanjoy Dutta and Esther Latres, JDRF, New YorkGina Agiostratidou and Anne Koralova, Helmsley Charitable Trust, New YorkBeena Akolkar, NIDDK, NIH, Bethesda
SESSION 6: REPORTS FROM CURRENT GENERAL POPULATION SCREENING PROGRAMS
9:00-9:30 (Peter Achenbach, Munich, Germany) (Slides)
9:30-9:50 (Daniel Agardh, Malmo, Sweden) (Slides)
9:50-10:10 (Kirstine Bell, Sydney, Australia) (Slides)
10:10-10:30 (Diane Wherrett, Toronto, Canada) (Slides)
10:30-10:45
10:45-11:00 (Cristy Geno Rasmussen, Denver, USA) (Slides)
11:00-11:15 (Anastasia Albanese-O'Neill, JDRF, USA) (Slides)
11:15-11:30 (Stephen Rich, Charlottesville, USA) (Slides)
11:30-11:45 (Kurt Griffin, Sioux Falls, USA) (Slides)
11:45-12:00 (William Hagopian, Seattle, USA) (Slides)
12:15-12:30
12:30-1:00 Lunch
SESSION 7: STANDARDIZATION OF IMMUNE MARKERS FOR SCREENING AND CONFIRMATION
1:00-1:20 (Peter Achenbach, Munich, Germany) (Slides)
1:20-1:40 (Vito Lampasona, Milan, Italy) (Slides)
1:40-2:00 (Liping Yu, Denver, USA) (Slides)
2:00-2:30
2:30-2:45 Break
SESSION 8: GUIDELINES FOR MONITORING AND EDUCATION IN PRE-SYMPTOMATIC T1D
2:45-3:05 (Linda DiMeglio, Indianapolis, USA) (Slides)
3:05-3:25 (Kimber Simmons, Denver, USA) (Slides)
3:25-3:45 (Rifka Schulman-Rosenbaum, New York, USA) (Slides)
3:45-4:05 (Brigitte Frohnert, Denver, USA) (Slides)
4:05-4:25 (Kimberly Driscoll, Gainesville, USA) (Slides)
4:25-4:40
4:40 (Marian Rewers, Denver USA) (Slides)
This program was developed independently by the Barbara Davis Center for Diabetes and supported in part by educational grants from Sanofi US and the Children's Diabetes Foundation.